Skip to main navigation Skip to search Skip to main content

Area deprivation index and breast cancer outcomes among patients in Western New York

  • Malak Alharbi
  • , Jayasree Krishnan
  • , Arya Mariam Roy
  • , Archit Patel
  • , Ankita Kapoor
  • , Riya Patel
  • , Kayla Catalfamo
  • , Kristopher Attwood
  • , Han Yu
  • , Varsha Gupta
  • , Sheheryar Kabraji
  • , Kazuaki Takabe
  • , Thaer Khoury
  • , Ellis Levine
  • , Angela Omilian
  • , Elizabeth Bouchard
  • , Song Yao
  • , Shipra Gandhi

Research output: Contribution to journal › Article › peer-review

Abstract

Background: Several studies have shown that residing in regions with high area deprivation index (ADI) is associated with worse outcomes. We evaluated associations between ADI and breast cancer (BC) outcomes among patients in Western New York (WNY), a region that includes multiple underserved areas. Methods: This retrospective, single-institution study analyzed data from 404 BC patients diagnosed between 2014 and 2018. Demographic and clinicopathological data were abstracted. Data were compared between high (≥ 60) and low (< 60) ADI groups, reflective of high and low levels of socioeconomic disadvantage, respectively. The primary objective was overall survival (OS) by ADI. Secondary objectives included assessment of recurrence free survival (RFS) or time to next treatment (TNT) by ADI and frequency of germline and somatic testing. Results: Over half of the patients (59%) resided in ADI ≥ 60. 77% of patients had stage I-III BC and 23% had de novo metastatic BC. Patients in ADI ≥ 60 had a lower 5-year OS rate (73%) than those in ADI < 60 (84%) (95%CI: 67.5–79.7, P = 0.05). In multivariable analysis, similar trend was observed but was not statistically significant (HR 1.56, 95%CI: 0.98–2.46, P = 0.058). There were no differences in TNT or RFS by ADI. Germline testing was performed less frequently (33%) in ADI ≥ 60 than ADI < 60 group (45%) (P = 0.04) for patients with stage I-III BC, while no difference observed for stage IV patients. Finally, prevalence of somatic mutations in TP53, PIK3CA, and ESR1 were higher in ADI ≥ 60. Conclusions: We observed a trend towards worse OS in areas with high ADI, though not statistically significant. The incidence of germline testing was lower in high ADI compared to low ADI regions.

Original languageEnglish
Pages (from-to)21-31
Number of pages11
JournalBreast Cancer Research and Treatment
Volume213
Issue number1
DOIs
StatePublished - Aug 2025

Keywords

  • Area deprivation index
  • Breast cancer
  • Healthcare disparities

Fingerprint

Dive into the research topics of 'Area deprivation index and breast cancer outcomes among patients in Western New York'. Together they form a unique fingerprint.

Cite this